ArticleThe Journal of international medical research2026
A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo develop and validate an integrated prognostic model based on tumor immune microenvironmental, systemic inflammatory, and coagulation markers to improve prognostic stratification and personalize management for bladder cancer patients undergoing surgery.MethodsThis retrospective study analyzed 140 patients who underwent radical or partial cystectomy at our institution between 2013 and 2021. Cutoff values for continuous variables were determined using receiver operating characteristic analysis. Independent prognostic factors for overall survival were identified using univariate and multivariate Cox regression analyses. A nomogram was subsequently developed and validated using time-dependent receiver operating characteristic curves, calibration plots, and decision curve analysis.ResultsMultivariate analysis confirmed that tertiary lymphoid structure density, hemoglobin level, D-dimer level, platelet-to-lymphocyte ratio, and clinical stage are independent predictors of overall survival. The constructed nomogram demonstrated high predictive accuracy for 1-, 3-, and 5-year overall survivals, with area under the curve values of 0.868, 0.880, and 0.894, respectively. Calibration and decision curve analyses confirmed the model's excellent consistency and clinical utility. Risk stratification based on the nomogram revealed significant survival differences between the groups (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.